Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of medical diagnostics and life science market reports and custom research services


Immuno-Oncology Diagnostics Markets: Nobel Prize Edition

Be the first to review this product

"A revolution in cancer therapy to be driven by new diagnostics. Histology, genomics and liquid biopsy converge..."

You can choose to pay by purchase order during checkout

Availability: In stock


* Required Fields

You can choose to pay by purchase order during checkout
Howe Sound Research

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description


Updated October 25, 2018

Table of Contents

Market Forecasts for Immuno-Oncology Diagnostics with Executive and Consultant Guides, Including Customized Forecasting and Analysis 2019 to 2023

"Nobel Prize signals move of immuno-oncology to a frontline role.  Diagnostics to play a leading role in treatment selection.…”

"A revolution in cancer therapy to be driven by new diagnostics.  Histology, genomics and liquid biopsy converge..."

This special Nobel Prize Edition of our new immuno-oncology diagnostics research report has been designed to bring all members of the management team up to date in this exciting, rapidly developing area.  The corporate license is presented as a private label report with the branding of your organization and is licensed for widespread distribution within your organization. 

A revolution in cancer therapy is underway. New therapy based on using the body’s natural immune defenses is having unprecedented success.  However diagnostics, especially biomarkers are desperately needed to help select the right therapy. This is a complex area and our readable report helps you understand from both the technological and opportunity aspects.

The technology is moving faster than the market. Already worth billions the global market is poised for dramatic growth.  Is the cure in sight?  The impact on the global healthcare industry is enormous.

Tumor Mutational Burden (TMB)?  Checkpoint Inhibitors?  Cytokines?  Find out about the technology in readily understood terms that explain the jargon.  Find the opportunities and the pitfalls.  Understand growth expectations and the ultimate potential market size.

All report data is available in Excel format on request.

Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report.  Check all your licensing options, however your order is available as a credit if you wish to upgrade. We wrote this report and are ready by phone or email to help you use it. 

Assistance and additional breakout data relevant to your own area(s) of interest is available free of charge with the corporate license.



Mr. Greg Powell, B.SC., M.B.A is an experienced business and clinical professional.  He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping."  He has worked in laboratory testing and management for over 20 years.  Mr. Powell’s education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Additional Information

Additional Information

Publisher name Howe Sound Research
Format PDF
Page count 217
Publication date 10 Oct 2018
Table of contents

Table of Contents

Report sample

Sample company listing


Write Your Own Review

Only registered users can write reviews. Please, log in or register

Product Tags

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.